Precigen provides pipeline and corporate updates at the 40th annual j.p. morgan healthcare conference

Germantown, md., jan. 12, 2022 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today presented pipeline and corporate updates at the 40th annual j.p.
PGEN Ratings Summary
PGEN Quant Ranking